249
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Role of ischemia-modified albumin in the evaluation of oxidative stress in intrahepatic cholestasis of pregnancy

ORCID Icon, , , , , ORCID Icon, & show all
Pages 3836-3840 | Received 14 Dec 2017, Accepted 07 May 2018, Published online: 17 Jun 2018

References

  • Dixon PH, Williamson C. The pathophysiology of intrahepatic cholestasis of pregnancy. Clin Res Hepatol Gastroenterol. 2016;40(2):141–153.
  • Roncaglia N, Arreghini A, Locatelli A, et al. Obstetric cholestasis: outcome with active management. Eur J Obstet Gynecol Reprod Biol. 2002;100(2):167–170.
  • Geenes V, Williamson C. Liver disease in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015;29(5):612–624.
  • Tayyar A, Temel Yuksel I, Koroglu N, et al. Maternal copeptin levels in intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med. 2018;31(15):2066–2070.
  • Roncaglia N, Locatelli A, Arreghini A, et al. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis. BJOG. 2004;111(1):17–21.
  • Sepúlveda WH, González C, Cruz MA, et al. Vasoconstrictive effect of bile acids on isolated human placental chorionic veins. Eur J Obstet Gynecol Reprod Biol. 1991;42(3):211–215.
  • Wikström Shemer E, Thorsell M, Östlund E, et al. Stereological assessment of placental morphology in intrahepatic cholestasis of pregnancy. Placenta. 2012;33(11):914–918.
  • Reid R, Ivey KJ, Rencoret RH, et al. Fetal complications of obstetric cholestasis. Br Med J. 1976;1(6014):870–872.
  • Wang XD, Liu SY, Heng ZC. Study on mechanism of fetal asphyxia in intrahepatic cholestasis of pregnancy. Chin J Obstet Gynecol. 1998;2:68.e70.
  • Yarcı Gursoy A, Caglar GS, Demirtas S. Ischemia modified albumin in perinatology. Eur J Obstet Gynecol Reprod Biol. 2017;210:182–188.
  • Özdemir S, Kıyıcı A, Balci O, et al. Assessment of ischemia-modified albumin level in patients with recurrent pregnancy loss during the first trimester. Eur J Obstet Gynecol Reprod Biol. 2011;155(2):209–212.
  • Ustün Y, Engin-Ustün Y, Oztürk O, et al. Ischemia-modified albumin as an oxidative stress marker in preeclampsia. J Matern Fetal Neonatal Med. 2011;24(3):418–421.
  • Pollack CV, Peacock WF, Summers RW. Ischemia-modified albumin (IMA) is useful in risk stratification of emergency department chest pain patients. Acad Emerg Med. 2003;10(5):555–556.
  • Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia – a preliminary report. J Emerg Med. 2000;19(4):311–315.
  • Van der Zee PM, Verberne HJ, van Straalen JP, et al. Ischemia-modified albumin measurements in symptom-limited exercise myocardial perfusion scintigraphy reflect serum albumin concentrations but not myocardial ischemia. Clin Chem. 2005;51(9):1744–1746.
  • Boyer JL. New perspectives for the treatment of cholestasis: lessons from basic science applied clinically. J Hepatol. 2007;46(3):365–371.
  • Hagenbuch B, Dawson P. The sodium bile salt cotransport family SLC10. Pflugers Arch. 2004;447(5):566–570.
  • Lippi G, Montagnana M, Guidi GC. Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia? Int J Cardiol. 2006;108(3):410–411.
  • Bhagavan NV, Lai EM, Rios PA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ıschemia and myocardial ınfarction. Clin Chem. 2003;49(4):581–585.
  • Prosser CC, Yen RD, Wu J. Molecular therapy for hepatic injury and fibrosis: where are we? World J Gastroenterol. 2006;12(4):509–515.
  • Biesiada L, Pietrzak Z, Brocka U, et al. Markers of oxidative stress in pregnancies complicated by pregnancy induced hypertension and intrahepatic cholestasis. Ginekol Pol. 2007;78(12):956–960.
  • Sanhal CY, Daglar K, Kara O, et al. An alternative method for measuring oxidative stress in intrahepatic cholestasis of pregnancy: thiol/disulphide homeostasis. J Matern Fetal Neonatal Med. 2018;31(11):1477–1482.
  • Kondrackiene J, Kupcinskas L. Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems. World J Gastroenterol. 2008;14(38):5781–5788.
  • Wei W, Hu YY. Expression of hypoxia-regulated genes and glycometabolic genes in placenta from patients with intrahepatic cholestasis of pregnancy. Placenta. 2014;35(9):732–736.
  • Perez MJ, Briz O. Bile-acid-induced cell injury and protection. World J Gastroenterol. 2009;15(14):1677–1689.
  • Dann AT, Kenyon AP, Seed PT, et al. Glutathione S-transferase and liver function in intrahepatic cholestasis of pregnancy and pruritus gravidarum. Hepatology. 2004;40(6):1406–1414.
  • Forkman B, Ganrot PO, Gennser G, et al. Plasma protein pattern in recurrent cholestasis of pregnancy. Scand J Clin Lab Invest Suppl. 1972;124:89–96.
  • Kenyon AP, Piercy CN, Girling J, et al. Obstetric cholestasis, outcome with active management: a series of 70 cases. BJOG. 2002;109(3):282–288.
  • Ma SG, Yu WN, Jin Y, et al. Evaluation of serum ischemia-modified albumin levels in pregnant women with and without gestational diabetes mellitus. Gynecol Endocrinol. 2012;28(11):837–840.
  • Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology. 2004;40(2):467–474.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.